Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vertex Pharma | Mexico | Healthcare | Biotechnology & Medical Research | MXN 2.54T | -258x | 2.17 | MXN 9,686 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Moderna | Mexico | Healthcare | Biotechnology & Medical Research | MXN 269.38B | -5.9x | -0.19 | MXN 701.20 | -15% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CRISPR Therapeutics AG | Mexico | Healthcare | Biotechnology & Medical Research | MXN 70.80B | -13.9x | -0.42 | MXN 880 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
FibroGen | Mexico | Healthcare | Biotechnology & Medical Research | MXN 956.42M | -0.4x | -0.01 | MXN 9.83 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |